Cyclo Therapeutics, Inc. (NASDAQ:CYTH – Get Free Report) was the target of a significant increase in short interest during the month of December. As of December 31st, there was short interest totalling 331,200 shares, an increase of 83.3% from the December 15th total of 180,700 shares. Currently, 3.1% of the company’s stock are short sold. […]
Item 8.01 Other Events. Other Events As previously announced, on September 21, 2023, Cyclo Therapeutics, Inc. and Cameo Merger Sub, Inc., a Delaware corporation.
Cyclo Therapeutics (CYTH) Reports Positive Outcome from Type C Meeting with the U S FDA Discussing Trappsol Cyclo streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.